CONMED director acquires 500 shares via RSUs

CONMED director Kim Kelderman converted 500 restricted stock units into 500 common shares as part of equity compensation.

Rhea-AI Filing Summary

CONMED Corp (CNMD) reported that director Kim Kelderman exercised 500 RSUs into 500 shares of Common Stock on September 8, 2026. The RSUs represented a contingent right to receive one share of common stock per unit under CONMED’s 2025 Long-Term Incentive Plan, which generally vests 100% after one year. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

500 shares exercised/converted

Exercise 2 txns

Insider Kelderman Kim

Role Director

Type	Security	Shares	Price	Value
Exercise	RSUs (Restricted Stock Units) F1	500	$0.00	$0.00
Exercise	Common Stock	500	$0.00	$0.00

Holdings After Transaction: RSUs (Restricted Stock Units) — 0 contracts (Direct); Common Stock — 500 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

Key Figures

RSUs exercised: 500 units Common shares acquired: 500 shares RSU balance after transaction: 0 units +2 more

5 metrics

RSUs exercised 500 units RSUs converted into common stock on September 8, 2026

Common shares acquired 500 shares Shares received from RSU exercise on September 8, 2026

RSU balance after transaction 0 units Reported RSUs following the September 8, 2026 exercise

Common stock held after transaction 500 shares Direct ownership reported following the RSU conversion

RSU vesting period 1 year RSUs generally vest 100% after a one-year period under the 2025 Plan

Key Terms

Restricted Stock Units, contingent right, Long-Term Incentive Plan

3 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of common stock"

Long-Term Incentive Plan financial

"subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"

A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.

FAQ

What insider transaction did CONMED Corp (CNMD) disclose for Kim Kelderman?

CONMED disclosed that director Kim Kelderman exercised 500 RSUs into 500 shares of Common Stock on September 8, 2026, reflecting the settlement of previously granted restricted stock units into shares.

How many CONMED (CNMD) shares were involved in Kim Kelderman’s Form 4 filing?

The filing reports an exercise of 500 RSUs, resulting in the acquisition of 500 shares of Common Stock by Kim Kelderman on September 8, 2026.

What happened to Kim Kelderman’s RSUs in the latest CNMD Form 4?

Kim Kelderman’s 500 RSUs were exercised on September 8, 2026, reducing his reported RSU balance in this filing to 0 and converting them into 500 shares of CONMED common stock.

Under which plan were Kim Kelderman’s CONMED (CNMD) RSUs granted?

The RSUs were granted under CONMED Corporation’s 2025 Long-Term Incentive Plan, with each RSU representing a contingent right to receive one share of common stock and generally vesting 100% after a one-year period.

Was Kim Kelderman’s CONMED (CNMD) RSU exercise under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, so no Rule 10b5-1 trading plan is reported in connection with these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 03:14 PM Accepted by SEC EDGAR 09/10/2026 - 03:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelderman Kim

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FLORIDA 33773

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		M		500	A	$0	500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	09/08/2026		M			500	09/08/2026(1)	09/08/2035	Common Stock	500	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

	/s/ Thomas Fistek for Kim Kelderman by Power of Attorney	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)